Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Noens

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Nuclear Medicine Communications|November 2, 2002
18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patientsB Van Den Bossche, B Lambert, F De Winter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 28, 1990
Enzymatic erythrocyte creatine determinations as an index for cell ageA M Buysse, J R Delanghe, M L De Buyzere, et al.
Acta Clinica Belgica|April 25, 2007
Guidelines for the transfusion of plateletsA Bosly, L Muylle, L Noens, et al.
Cancer Genetics and Cytogenetics|August 1, 1984
Interstitial 9q- deletions in hematologic malignanciesC Mecucci, K Vermaelen, G Kulling, et al.
Acta Clinica Belgica|September 20, 2014
Plerixafor prescription modalities in autologous haematopoietic stem cell mobilization in BelgiumD Selleslag, C Lambert, P Zachee, et al.
Cancer Genetics and Cytogenetics|December 1, 1989
Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndromeA Iurlo, C Mecucci, A Van Orshoven, et al.
Annals of Hematology|March 23, 2004
Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trialG Heil, J Krauter, A Raghavachar, et al.
Cancer Genetics and Cytogenetics|September 1, 1983
Anomalies of the long arm of chromosome 11 in human myelo- and lymphoproliferative disorders. I. Acute nonlymphocytic leukemiaK Vermaelen, D Barbieri, J L Michaux, et al.
Haematologica|July 16, 1999
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factorM F Dresse, M Boogaerts, C Vermylen, et al.
Blood|January 7, 1998
A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study GroupG Heil, D Hoelzer, M A Sanz, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Nuclear Medicine Communications|November 2, 2002
18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patientsB Van Den Bossche, B Lambert, F De Winter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 28, 1990
Enzymatic erythrocyte creatine determinations as an index for cell ageA M Buysse, J R Delanghe, M L De Buyzere, et al.
Acta Clinica Belgica|April 25, 2007
Guidelines for the transfusion of plateletsA Bosly, L Muylle, L Noens, et al.
Cancer Genetics and Cytogenetics|August 1, 1984
Interstitial 9q- deletions in hematologic malignanciesC Mecucci, K Vermaelen, G Kulling, et al.
Acta Clinica Belgica|September 20, 2014
Plerixafor prescription modalities in autologous haematopoietic stem cell mobilization in BelgiumD Selleslag, C Lambert, P Zachee, et al.
Cancer Genetics and Cytogenetics|December 1, 1989
Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndromeA Iurlo, C Mecucci, A Van Orshoven, et al.
Annals of Hematology|March 23, 2004
Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trialG Heil, J Krauter, A Raghavachar, et al.
Cancer Genetics and Cytogenetics|September 1, 1983
Anomalies of the long arm of chromosome 11 in human myelo- and lymphoproliferative disorders. I. Acute nonlymphocytic leukemiaK Vermaelen, D Barbieri, J L Michaux, et al.
Haematologica|July 16, 1999
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factorM F Dresse, M Boogaerts, C Vermylen, et al.
Blood|January 7, 1998
A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study GroupG Heil, D Hoelzer, M A Sanz, et al.
Pageof 4